文献速递胃肠动力与功能性疾病食管胃疾病与幽门螺杆菌

难治性反流症状患者中食管脑-肠轴互动障碍与胃食管反流病重叠高度 prevalent

Overlap of Esophageal Disorders of Gut-Brain Interactions and Gastroesophageal Reflux Disease Is Highly Prevalent in Patients With Refractory Reflux Symptoms.
PubMed 文献 · Am J Gastroenterol · 2025-05-22

这项前瞻性研究纳入119例典型难治性反流症状患者,发现证实GERD组中72%存在GERD与E-DGBI重叠,未证实GERD组中68.5%为E-DGBI。功能性消化不良(70.6%)和肠易激综合征(33.6%)高发,各组焦虑、抑郁及内脏敏感性无差异;证实难治性GERD组酸暴露时间及反流次数高于重叠组。

要点

  • 证实GERD的难治性反流患者中72%重叠E-DGBI。
  • 未证实GERD者中68.5%为E-DGBI,功能性消化不良占70.6%。
  • 重叠组与证实难治性GERD组症状、焦虑抑郁及内脏敏感性无差异。

核心结论

  • E-DGBI在证实GERD且伴难治性反流症状的患者中高度流行。
  • 需要结局数据的研究来确定重叠E-DGBI与GERD的患者是否应在考虑介入治疗前通过PPI治疗下的pH-阻抗监测识别。

研究设计与样本

  • 前瞻性纳入典型难治性反流症状患者,共119例。
  • 收集年龄、性别、主要症状、pH及pH-阻抗监测、食管动力障碍及内镜结果。
  • 将患者分类为未证实GERD、证实GERD、单纯E-DGBI、难治性GERD及GERD与E-DGBI重叠。
  • 获取反流症状、其他DGBI、焦虑抑郁水平及内脏敏感性问卷。

主要发现

  • 46例证实GERD患者中,13例(28%)为单纯难治性GERD,33例(72%)为GERD与E-DGBI重叠。
  • 未证实GERD组中,23例(31.5%)为GERD,50例(68.5%)为E-DGBI。
  • 功能性消化不良占70.6%,肠易激综合征占33.6%。
  • 症状表现、焦虑、抑郁及内脏敏感性评分无差异。
  • 证实难治性GERD组较重叠E-DGBI-GERD组酸暴露时间更高、反流次数更多。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Esophageal disorders of gut-brain interaction (E-DGBIs) are highly prevalent in patients with unproven gastroesophageal reflux disease (GERD) who do not respond to proton pump inhibitors (PPIs). The aim of this study was to determine the prevalence and characteristics of confirmed refractory GERD and E-DGBIs in consecutive patients with refractory reflux symptoms. METHODS: Patients with typical refractory reflux symptoms were prospectively enrolled. Data on age, sex, primary symptoms, pH and pH-impedance monitoring, presence of esophageal motor disorders, and endoscopy results were collected. Patients were classified as unproven and proven GERD, E-DGBI alone, refractory GERD, and overlap between GERD and E-DGBI. Questionnaires were obtained for reflux symptoms, presence of other DGBIs, levels of anxiety and depression, and visceral sensitivity. RESULTS: A total of 119 patients were included. Among 46 patients with proven GERD, 13 (28%) had isolated refractory GERD and 33 (72%) had an overlap of GERD and E-DGBIs. Among the unproven GERD group, 23 (31.5%) had GERD and 50 (68.5%) had an E-DGBI. Functional dyspepsia (70.6%) and irritable bowel syndrome (33.6%) were highly prevalent. No difference was found in symptom presentation, anxiety, depression, and visceral sensitivity scores. A higher acid exposure time and number of reflux episodes were found in patients with confirmed refractory GERD compared with the overlap E-DGBI-GERD group. DISCUSSION: E-DGBIs are highly prevalent in patients with proven GERD and refractory reflux symptoms. Studies with outcome data are needed to determine whether patients with overlapping E-DGBIs and GERD should be identified with pH-impedance monitoring on PPI therapy before an interventional treatment option is considered.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Caldart F, Gabriel C, Vauquelin B, et al. Overlap of Esophageal Disorders of Gut-Brain Interactions and Gastroesophageal Reflux Disease Is Highly Prevalent in Patients With Refractory Reflux Symptoms. Am J Gastroenterol. 2025. PMID: 40402176. doi:10.14309/ajg.0000000000003542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。